Director at Omada Health (OMDA) receives 10,882 RSUs compensation award

Rhea-AI Filing Summary

Omada Health, Inc. director Jonathan D. Root received a grant of 10,882 restricted stock units, representing a stock-based compensation award with no cash purchase price. These RSUs convert into one share of common stock each upon vesting, with all units vesting on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, subject to continued service. Following this grant, Root holds 191,057 shares of common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ROOT JONATHAN D

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,882	$0.00	--

Holdings After Transaction: Common Stock — 191,057 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 10,882 RSUs Transaction price: $0.0000 per share Post-grant holdings: 191,057 shares +1 more

4 metrics

RSU grant size 10,882 RSUs Award to director Jonathan D. Root on transaction date

Transaction price $0.0000 per share RSU grant with no cash exercise or purchase price

Post-grant holdings 191,057 shares Total common stock beneficially owned after the RSU award

Vesting trigger First anniversary or 2027 meeting RSUs fully vest on earlier of grant’s first anniversary or 2027 Annual Meeting, subject to service

Key Terms

restricted stock units, RSUs, vesting, beneficially owned

4 terms

restricted stock units financial

"Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

vesting financial

"100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

beneficially owned financial

"total_shares_following_transaction": "191057.0000""

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROOT JONATHAN D

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A		10,882(1)	A	$0	191,057	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.

	/s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Omada Health (OMDA) director Jonathan D. Root report in this Form 4?

Jonathan D. Root reported receiving 10,882 restricted stock units as a stock-based award. Each RSU converts into one share of common stock upon vesting, increasing his holdings to 191,057 shares after the grant.

Is the Omada Health (OMDA) Form 4 transaction an open-market stock purchase?

No, the Form 4 shows a grant of 10,882 restricted stock units with a zero-dollar price. This is a compensation award, not an open-market purchase of Omada Health common stock by the director.

How do the 10,882 Omada Health (OMDA) RSUs for Jonathan D. Root vest?

The 10,882 RSUs fully vest on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, provided Jonathan D. Root continues to serve through the applicable vesting date.

What is Jonathan D. Root’s Omada Health (OMDA) share ownership after this RSU grant?

After the grant, Jonathan D. Root is reported as beneficially owning 191,057 shares of Omada Health common stock. This figure reflects his position following the 10,882 restricted stock units reported in the Form 4.

Does the Omada Health (OMDA) RSU grant to Jonathan D. Root involve any exercise price?

No, the RSU grant shows a transaction price of $0.0000 per share. Restricted stock units are typically awarded without an exercise price and convert into common shares upon satisfying vesting conditions.

What type of insider transaction code appears in the Omada Health (OMDA) Form 4?

The Form 4 uses transaction code “A,” indicating a grant, award, or other acquisition. In this case, it represents the award of 10,882 restricted stock units to director Jonathan D. Root.